AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,581 | +7.4% | 22,608 | +10.4% | 0.00% | – |
Q2 2023 | $1,472 | +46.8% | 20,476 | +26.0% | 0.00% | – |
Q1 2023 | $1,003 | -10.2% | 16,249 | +12.2% | 0.00% | – |
Q4 2022 | $1,117 | -99.8% | 14,479 | +2.7% | 0.00% | – |
Q3 2022 | $630,000 | +12.5% | 14,099 | -3.6% | 0.00% | – |
Q2 2022 | $560,000 | -5.9% | 14,627 | +1.7% | 0.00% | – |
Q1 2022 | $595,000 | +52.6% | 14,382 | +39.4% | 0.00% | – |
Q4 2021 | $390,000 | -41.2% | 10,314 | -48.7% | 0.00% | – |
Q3 2021 | $663,000 | -98.7% | 20,110 | -97.3% | 0.00% | -100.0% |
Q2 2021 | $50,477,000 | +42.1% | 748,247 | +19.3% | 0.01% | +25.0% |
Q1 2021 | $35,520,000 | -58.0% | 627,338 | -39.6% | 0.00% | -55.6% |
Q4 2020 | $84,668,000 | +13.3% | 1,039,255 | -0.9% | 0.01% | 0.0% |
Q3 2020 | $74,740,000 | -16.3% | 1,048,985 | -3.3% | 0.01% | -18.2% |
Q2 2020 | $89,263,000 | +103.6% | 1,084,871 | +45.5% | 0.01% | +57.1% |
Q1 2020 | $43,850,000 | -73.6% | 745,360 | -53.6% | 0.01% | -68.2% |
Q4 2019 | $166,099,000 | +1057.6% | 1,606,991 | +126.7% | 0.02% | +1000.0% |
Q3 2019 | $14,348,000 | -3.7% | 708,871 | +22.5% | 0.00% | 0.0% |
Q2 2019 | $14,906,000 | – | 578,859 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |